CAR-T cell therapy

What this capability means

CAR-T (chimeric antigen receptor T-cell) therapy: a patient's T cells are collected, genetically engineered and reinfused to treat certain blood cancers. Eligibility requires hospital assessment based on disease type, prior treatment and general condition.

Evidence level: A · Category: cell_therapy

Hospitals with A-level credentials

Main list only includes manufacturer, MOH or national-society credentials.

Compare hospitals

Scroll sideways to compare all columns. No ordering is implied.

Risks and boundaries

• This page lists public credentials only; it is not a medical recommendation or hospital ordering.
• Treatment eligibility, preparation, complications and follow-up require assessment by the treating hospital.
• Public drug prices, when shown, are not a treatment quotation and may change.
• Confirm the current credential, product, appointment availability and international-patient acceptance with the hospital.

Sources for this page: jwtherapeutics.com · fosunkairos.com

Frequently asked questions

Which hospitals in China provide CAR-T cell therapy?

13 hospitals with A-level credentials are listed on this page. The list is based on public manufacturer/MOH/society lists; each row shows its verification date.

What does a manufacturer-certified centre mean?

It means the centre appears on the manufacturer's published training/certification list for this product. It is a credential statement, not a ranking or a guarantee of outcomes.

Is the cost publicly available?

Public drug prices are shown only when a reliable source is available. They are drug prices, not a treatment quotation; hospital assessment and the full plan determine the final cost.

Can international patients receive this treatment here?

Acceptance of international patients is to be confirmed with each hospital. This page does not promise appointments, eligibility or outcomes.

How was this list verified?

The page is based on public manufacturer/MOH/society lists and hospital-published information, last reviewed 2026-10-23. Confirm the current credential and treatment plan with the hospital.

Sources and last review

Last reviewed: 2026-10-23

• jwtherapeutics.com2026-10-23
• fosunkairos.com2026-10-23